The only PSGAG approved disease-modifying OA drug (DMOAD), Adequan® Canine (polysulfated glycosaminoglycan) empowers you to treat the disease and not just the clinical signs of canine osteoarthritis.
For intramuscular use in dogs.
Each mL of Adequan® Canine contains 100 mg Polysulfated Glycosaminoglycan (PSGAG), 0.009 mL benzyl alcohol as a preservative, and water for injection.
Adequan® Canine is recommended for the treatment of non-infectious degenerative and/or traumatic arthritis and associated lameness of canine synovial joints.
2 x 5 ml multiple dose vials per box